Share

Nanjing Vishee Medical Technology Co., Ltd Stocks

CN¥ 64.26Last Updated 30.04.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

CN¥ 901.48M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 64.26
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nanjing Vishee Medical Technology Co., Ltd. develops and manufactures medical rehabilitation devices in China. It offers pelvic floor and postpartum, neurological, and mental rehabilitation solutions; and bio-stimulation feedback devices, magnetic stimulators, etc. The company's solutions cover markets, such as electrical and magnetic stimulation, electrophysiology, and other technical directions. It offers its products through dealers, sales network, and distributors to hospitals, and terminal medical and professional institutions. The company was founded in 2001 and is based in Nanjing, China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 688580.SS is 60 and suggests 7% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks